Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

1
(from Reference Citation Analysis)

Article PDFs (1)

Cited by > 0 (1)

Searched Name

transcriptional states

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Raghavan S, Winter PS, Navia AW, Williams HL, DenAdel A, Lowder KE, Galvez-Reyes J, Kalekar RL, Mulugeta N, Kapner KS, Raghavan MS, Borah AA, Liu N, Väyrynen SA, Costa AD, Ng RW, Wang J, Hill EK, Ragon DY, Brais LK, Jaeger AM, Spurr LF, Li YY, Cherniack AD, Booker MA, Cohen EF, Tolstorukov MY, Wakiro I, Rotem A, Johnson BE, McFarland JM, Sicinska ET, Jacks TE, Sullivan RJ, Shapiro GI, Clancy TE, Perez K, Rubinson DA, Ng K, Cleary JM, Crawford L, Manalis SR, Nowak JA, Wolpin BM, Hahn WC, Aguirre AJ, Shalek AK. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell 2021;184:6119-6137.e26. [PMID: 34890551 PMCID: PMC8822455 DOI: 10.1016/j.cell.2021.11.017] [Citation(s) in RCA: 165] [Impact Index Per Article: 55.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2021] [Revised: 09/24/2021] [Accepted: 11/11/2021] [Indexed: 01/13/2023]

Affiliation(s)

Srivatsan Raghavan Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,3Harvard Medical School, Boston, MA 02115, USA,4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA,20These authors contributed equally
Peter S. Winter Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,5Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,6Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,7Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,20These authors contributed equally,*Correspondence: (P.S.W.), (A.J.A.), (A.K.S.)
Andrew W. Navia Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,5Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,6Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,7Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,20These authors contributed equally
Hannah L. Williams Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA,20These authors contributed equally
Alan DenAdel Center for Computational Molecular Biology, Brown University, Providence, RI 02912, USA,9Division of Applied Mathematics, Brown University, Providence, RI 02912, USA
Kristen E. Lowder Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Jennyfer Galvez-Reyes Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,5Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,6Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Radha L. Kalekar Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Nolawit Mulugeta Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,5Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,6Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Kevin S. Kapner Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Manisha S. Raghavan Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Ashir A. Borah Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Nuo Liu Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,5Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,6Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Sara A. Väyrynen Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA
Andressa Dias Costa Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA
Raymond W.S. Ng Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Junning Wang Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Emma K. Hill Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Dorisanne Y. Ragon Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Lauren K. Brais Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Alex M. Jaeger Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Liam F. Spurr Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Yvonne Y. Li Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Andrew D. Cherniack Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,3Harvard Medical School, Boston, MA 02115, USA
Matthew A. Booker Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Elizabeth F. Cohen Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Michael Y. Tolstorukov Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Isaac Wakiro Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Asaf Rotem Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,11Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Bruce E. Johnson Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA,4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA,11Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA
James M. McFarland Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
Ewa T. Sicinska Harvard Medical School, Boston, MA 02115, USA,12Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Tyler E. Jacks Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
Ryan J. Sullivan Harvard Medical School, Boston, MA 02115, USA,13Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA
Geoffrey I. Shapiro Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA,4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
Thomas E. Clancy Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA,14Department of Surgery, Brigham and Women’s Hospital, Boston, MA 02115, USA
Kimberly Perez Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA,4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
Douglas A. Rubinson Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA,4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
Kimmie Ng Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA,4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
James M. Cleary Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA,4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA
Lorin Crawford Center for Computational Molecular Biology, Brown University, Providence, RI 02912, USA,15Department of Biostatistics, Brown University, Providence, RI 02912, USA,16Microsoft Research New England, Cambridge, MA 02142, USA
Scott R. Manalis Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,17Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
Jonathan A. Nowak Harvard Medical School, Boston, MA 02115, USA,11Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA,18Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115, USA
Brian M. Wolpin Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,3Harvard Medical School, Boston, MA 02115, USA,4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA,21These authors contributed equally,22Senior author
William C. Hahn Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,3Harvard Medical School, Boston, MA 02115, USA,4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA,21These authors contributed equally,22Senior author
Andrew J. Aguirre Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA,2Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,3Harvard Medical School, Boston, MA 02115, USA,4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA,21These authors contributed equally,22Senior author,*Correspondence: (P.S.W.), (A.J.A.), (A.K.S.)
Alex K. Shalek Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA,3Harvard Medical School, Boston, MA 02115, USA,5Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,6Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,7Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA,19Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA,21These authors contributed equally,22Senior author,23Lead contact,*Correspondence: (P.S.W.), (A.J.A.), (A.K.S.)

Collapse